comparemela.com

Latest Breaking News On - Zydis - Page 1 : comparemela.com

Awakn Life Sciences Corp : Awakn Life Sciences Initiates Feasibility Study for MDMA Using Catalent s Zydis Orally Disintegrating Tablet (ODT) Technology

Toronto, Ontario (Newsfile Corp. - February 9, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with

Gordo whittakerAnthony tennysonLinkedin facebookSchwierige zeitenShaun mcnultyAwakn life sciencesNewsfile corpAwakn life sciences corpLife sciencesAlcohol use disorderAwakn life

Catalent to Supply Edenbridge Pharmaceuticals with a Patient-Focused Fast-Dissolve Zydis Formulation of Glycopyrrolate Intended for Use as Adjunctive Therapy in the Treatment of Patients with Peptic Ulcer

SOMERSET, N.J.

United statesRyan collinsJonathan arnoldEdenbridge pharmaceuticalsSpecialty deliveryDrug discoveryHealth sciencesLife sciencesPharmaceutical industryDosage formsGene therapyOrally disintegrating tabletஒன்றுபட்டது மாநிலங்களில்ரியான் கோலின்ஸ்ஜொனாதன் அர்னால்ட்சிறப்பு டெலிவரி

vimarsana © 2020. All Rights Reserved.